Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2026-03-18 @ 5:25 PM
Study NCT ID:
NCT00436904
Status:
COMPLETED
Last Update Posted:
2011-12-01
First Post:
2007-02-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Alemtuzumab and Rituximab in Treating Patients With High-Risk, Early-Stage Chronic Lymphocytic Leukemia
Sponsor:
Mayo Clinic
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Leukemia | View |